Companies/Halo Collective Inc.

Company profile

Halo Collective Inc.

OTC: HCANF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Toronto, ONReports USD

#523 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 48

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, workforce scale · ↓ return on equity, market scale

Methodology →

Revenue TTM

$18.0M

Rev growth YoY (TTM)

-43.0%

Net income (FY)

-$83.9M

Employees

114

Market cap

$15.1k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$24.5M$24.5M2022

Net income-$83.9M-$83.9M2022

Operating income-$34.9M-$34.9M2022

Total assets$56.9M$56.9M2022

Liabilities$27.5M$27.5M2022

Equity$32.6M$32.6M2022

Revenue trend

FY2015 – FY2022 · USD

$5.1M

FY15

FY16

FY17

$10.9M

FY18

$28.1M

FY19

$21.6M

FY20

$36.2M

FY21

$24.5M

FY22

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Halo Collective Inc. booked $24.5M in FY2022 revenue, contracting 32% year over year — slower than 77% of Healthcare companies we track, at a -341.8% net margin.

Peers · Healthcare

Aeolus Pharmaceuticals, Inc.——Regenicin, Inc.——Body and Mind Inc.——VioQuest Pharmaceuticals, Inc.——

Key facts

CEOMarshall Minor

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, ON

ExchangeOTC: HCANF

Employees114

IPO date2010-09-22

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.